Neurological and cardiac responses after treatment with miglustat and a ketogenic diet in a patient with Sandhoff disease

Ives T. Villamizar-Schiller, Laudy A. Pabón, Sophia B. Hufnagel, Norma C. Serrano, Gabriela Karl, John Jefferies, Robert J. Hopkin, Carlos E. Prada

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Sandhoff disease is a progressive neurodegenerative disorder characterized by accumulation of GM2 gangliosides. We describe a 6-year-old male with coarse facial features, developmental delay, refractory seizures, hypertrophic cardiomyopathy, who was later found to have Sandhoff disease. Previous studies have revealed that caloric restriction in combination with miglustat increased survival and motor behavior in mouse model of Sandhoff disease. These findings suggest that combination therapy may result in improved outcomes for patients with Sandhoff. Initiation of treatment with miglustat and a ketogenic diet was followed by improvement of the patient's seizure control and cardiac function. Further clinical investigation is required to better determine the benefit of management in late-onset forms of Sandhoff disease.

Original languageEnglish (US)
Pages (from-to)180-183
Number of pages4
JournalEuropean Journal of Medical Genetics
Volume58
Issue number3
DOIs
StatePublished - Mar 1 2015

Fingerprint

Sandhoff Disease
Ketogenic Diet
Seizures
G(M2) Ganglioside
Caloric Restriction
Hypertrophic Cardiomyopathy
Therapeutics
Neurodegenerative Diseases
Survival
miglustat

All Science Journal Classification (ASJC) codes

  • Genetics
  • Genetics(clinical)

Cite this

Neurological and cardiac responses after treatment with miglustat and a ketogenic diet in a patient with Sandhoff disease. / Villamizar-Schiller, Ives T.; Pabón, Laudy A.; Hufnagel, Sophia B.; Serrano, Norma C.; Karl, Gabriela; Jefferies, John; Hopkin, Robert J.; Prada, Carlos E.

In: European Journal of Medical Genetics, Vol. 58, No. 3, 01.03.2015, p. 180-183.

Research output: Contribution to journalArticle

Villamizar-Schiller, Ives T. ; Pabón, Laudy A. ; Hufnagel, Sophia B. ; Serrano, Norma C. ; Karl, Gabriela ; Jefferies, John ; Hopkin, Robert J. ; Prada, Carlos E. / Neurological and cardiac responses after treatment with miglustat and a ketogenic diet in a patient with Sandhoff disease. In: European Journal of Medical Genetics. 2015 ; Vol. 58, No. 3. pp. 180-183.
@article{6aa09c73ffef4ef881e45ed99ebd945c,
title = "Neurological and cardiac responses after treatment with miglustat and a ketogenic diet in a patient with Sandhoff disease",
abstract = "Sandhoff disease is a progressive neurodegenerative disorder characterized by accumulation of GM2 gangliosides. We describe a 6-year-old male with coarse facial features, developmental delay, refractory seizures, hypertrophic cardiomyopathy, who was later found to have Sandhoff disease. Previous studies have revealed that caloric restriction in combination with miglustat increased survival and motor behavior in mouse model of Sandhoff disease. These findings suggest that combination therapy may result in improved outcomes for patients with Sandhoff. Initiation of treatment with miglustat and a ketogenic diet was followed by improvement of the patient's seizure control and cardiac function. Further clinical investigation is required to better determine the benefit of management in late-onset forms of Sandhoff disease.",
author = "Villamizar-Schiller, {Ives T.} and Pab{\'o}n, {Laudy A.} and Hufnagel, {Sophia B.} and Serrano, {Norma C.} and Gabriela Karl and John Jefferies and Hopkin, {Robert J.} and Prada, {Carlos E.}",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.ejmg.2014.12.009",
language = "English (US)",
volume = "58",
pages = "180--183",
journal = "European Journal of Medical Genetics",
issn = "1769-7212",
publisher = "Elsevier Masson SAS",
number = "3",

}

TY - JOUR

T1 - Neurological and cardiac responses after treatment with miglustat and a ketogenic diet in a patient with Sandhoff disease

AU - Villamizar-Schiller, Ives T.

AU - Pabón, Laudy A.

AU - Hufnagel, Sophia B.

AU - Serrano, Norma C.

AU - Karl, Gabriela

AU - Jefferies, John

AU - Hopkin, Robert J.

AU - Prada, Carlos E.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Sandhoff disease is a progressive neurodegenerative disorder characterized by accumulation of GM2 gangliosides. We describe a 6-year-old male with coarse facial features, developmental delay, refractory seizures, hypertrophic cardiomyopathy, who was later found to have Sandhoff disease. Previous studies have revealed that caloric restriction in combination with miglustat increased survival and motor behavior in mouse model of Sandhoff disease. These findings suggest that combination therapy may result in improved outcomes for patients with Sandhoff. Initiation of treatment with miglustat and a ketogenic diet was followed by improvement of the patient's seizure control and cardiac function. Further clinical investigation is required to better determine the benefit of management in late-onset forms of Sandhoff disease.

AB - Sandhoff disease is a progressive neurodegenerative disorder characterized by accumulation of GM2 gangliosides. We describe a 6-year-old male with coarse facial features, developmental delay, refractory seizures, hypertrophic cardiomyopathy, who was later found to have Sandhoff disease. Previous studies have revealed that caloric restriction in combination with miglustat increased survival and motor behavior in mouse model of Sandhoff disease. These findings suggest that combination therapy may result in improved outcomes for patients with Sandhoff. Initiation of treatment with miglustat and a ketogenic diet was followed by improvement of the patient's seizure control and cardiac function. Further clinical investigation is required to better determine the benefit of management in late-onset forms of Sandhoff disease.

UR - http://www.scopus.com/inward/record.url?scp=84924532523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924532523&partnerID=8YFLogxK

U2 - 10.1016/j.ejmg.2014.12.009

DO - 10.1016/j.ejmg.2014.12.009

M3 - Article

VL - 58

SP - 180

EP - 183

JO - European Journal of Medical Genetics

JF - European Journal of Medical Genetics

SN - 1769-7212

IS - 3

ER -